Literature DB >> 12012320

Molecular biology and immunoregulation of human neurotropic JC virus in CNS.

Thersa M Sweet1, Luis Del Valle, Kamel Khalili.   

Abstract

The human polyomavirus, JC virus (JCV), provides an excellent model system to investigate the reciprocal interaction of the immune and nervous systems. Infection with JCV occurs during childhood and the virus remains in the latent state with no apparent clinical symptoms. However, under immunosuppressed conditions, the virus enters the lytic cycle and upon cytolytic destruction of glial cells, causes the fatal demyelinating disease of the central nervous system (CNS), named progressive multifocal leukoencephalopathy (PML). In this short review, we discuss the molecular pathogenesis of PML by highlighting the role of the immune system in modulating JCV gene activation and replication, and the latency/reactivation of this virus upon immunosuppression. Further, due to the higher incidence of PML among AIDS patients, we further elaborate on the cross-talk between JCV and HIV-1 by direct and indirect pathways that lead to enhanced expression of the JCV genome. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12012320     DOI: 10.1002/jcp.10096

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Analysis of DNA-binding activity of the JC virus minor capsid protein VP2.

Authors:  Yih-Leh Huang; Meilin Wang; Wei-Chih Ou; Chiung-Yau Fung; Li-Sheng Chen; Deching Chang
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

2.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

3.  A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients.

Authors:  Duško Kozić; Mladen Bjelan; Jasmina Boban; Jelena Ostojić; Vesna Turkulov; Aleksandar Todorović; Slobodanka Lemajić-Komazec; Snežana Brkić
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

4.  Patients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment.

Authors:  Vinit B Mahajan; Edwin M Stone
Journal:  Am J Ophthalmol       Date:  2010-08-05       Impact factor: 5.258

Review 5.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

6.  Murine gammaherpesvirus-68 elicits robust levels of interleukin-12 p40, but not interleukin-12 p70 production, by murine microglia and astrocytes.

Authors:  Amy Rasley; Kenneth L Bost; Ian Marriott
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

7.  Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Authors:  Jason G Weinger; Warren C Plaisted; Sonia M Maciejewski; Lewis L Lanier; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

8.  JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.

Authors:  Roberta Mancuso; Marina Saresella; Ambra Hernis; Ivana Marventano; Cristian Ricci; Simone Agostini; Marco Rovaris; Domenico Caputo; Mario Clerici
Journal:  J Transl Med       Date:  2012-12-11       Impact factor: 5.531

9.  Extensive demyelinating change in cerebrum after a total knee replacement -A case report-.

Authors:  Sang-Jin Park; Seung-Dong Kim; Dae-Lim Jee; Woo-Mok Byun
Journal:  Korean J Anesthesiol       Date:  2010-12-31

10.  Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Sara Cioccolo; Rossana Scrivo; Manuela Morreale; Simona Pontecorvo; Federica Ferrari; Giovanni Di Nardo; Lucia Nencioni; Silvia Carluccio; Guido Valesini; Ada Francia; Salvatore Cucchiara; Anna Teresa Palamara; Valeria Pietropaolo
Journal:  Virol J       Date:  2013-09-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.